Metabolic Disease
| 5 min read
Explore how the gut microbiome impacts health. Learn about a new study that reveals how a specific microbe, P. faecium, may help fight obesity.
| 3 min read
A new compound, Vykat XR, addresses insatiable hunger in the rare genetic condition, offering relief for patients and hope for families.
| 3 min read
A new method for tracking dietary intake used DNA in stool to detect nutritional content from a broad range of foods.
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
| 10+ min read
GLP-1 agonists have transformed the treatment of type 2 diabetes and obesity, but they come with side effects. Physicians say the benefits outweigh the risks.
| 4 min read
Targeting a gut bacterial species or its metabolites could potentially improve diabetes management by reducing sugar preferences.
| 3 min read
Sagimet’s denifanstat delivered significant improvements in disease activity and fibrosis for patients with metabolic dysfunction-associated steatohepatitis.
| 3 min read
Injectable micelles that release glucagon could provide a new way to treat hypoglycemic events in diabetes.
| 10 min read
Customizable hydrogels could make taking diabetes and cancer medications as well as other biologics easier for patients.
| 2 min read
AMSBIO has launched a glucagon-like peptide 1 receptor (GLP-1R) reporter cell line.
| 3 min read
Specialized cells in omental adipose tissue may repress fat cell development.
| 5 min read
Paolo Martini leads the biotech company’s rare disease research program with the hope of developing the very first treatments for genetic metabolic disorders.
